A post-marketing study evaluating the lipid-altering efficacy and safety of approved dose ranges of rosuvastatin in Indian hyperlipidemia patients in routine clinical practice (ROSUVEES)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A post-marketing study evaluating the lipid-altering efficacy and safety of approved dose ranges of rosuvastatin in Indian hyperlipidemia patients in routine clinical practice (ROSUVEES)

Published:2015-12 Issue:4 Volume:5 Page:282-290
ISSN:1561-8811
Container-title:Journal of Indian College of Cardiology
language:en
Short-container-title:Journal of Indian College of Cardiology

Author:

Shah Chetan P.,Kumbla Dayanand K.,Moorthy Asha,Murthy S.,Aneja Pankaj,Gotur Jagdish,Gupta Anil,Abhi Raman,Bansal Rajeev,Sonawala Subhash,Balani Anil G.,Kedarnathan R.,Soni Pankaj,Chinnaiyan P.

Publisher

Medknow

Subject

General Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes mellitus;Endocrine;2020-09-07

2. Unfolding the pleiotropic facades of rosuvastatin in therapeutic intervention of myriads of neurodegenerative disorders;Clinical and Experimental Pharmacology and Physiology;2018-12-17

3. Regulating dyslipidemia effect of polysaccharides from Pleurotus ostreatus on fat-emulsion-induced hyperlipidemia rats;International Journal of Biological Macromolecules;2017-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP